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Abstract 
Background 
The financial costs associated with asthma care continue to increase while care remains 
suboptimal. Promoting optimal self-management, including the use of asthma action plans, 
along with regular health professional review has been shown to be an effective strategy and 
is recommended in asthma guidelines internationally. Despite evidence of benefit, guided 
self-management remains underused, however the potential for online resources to promote 
self-management behaviors is gaining increasing recognition. The aim of this paper is to 
describe the protocol for a pilot evaluation of a website ‘Living well with asthma’ which has 
been developed with the aim of promoting self-management behaviors shown to improve 
outcomes. 
Methods/Design 
The study is a parallel randomized controlled trial, where adults with asthma are randomly 
assigned to either access to the website for 12 weeks, or usual asthma care for 12 weeks 
(followed by access to the website if desired). Individuals are included if they are over 16-
years-old, have a diagnosis of asthma with an Asthma Control Questionnaire (ACQ) score of 
greater than, or equal to 1, and have access to the internet. Primary outcomes for this 
evaluation include recruitment and retention rates, changes at 12 weeks from baseline for 
both ACQ and Asthma Quality of Life Questionnaire (AQLQ) scores, and quantitative data 
describing website usage (number of times logged on, length of time logged on, number of 
times individual pages looked at, and for how long). Secondary outcomes include clinical 
outcomes (medication use, health services use, lung function) and patient reported outcomes 
(including adherence, patient activation measures, and health status). 
Discussion 
Piloting of complex interventions is considered best practice and will maximise the potential 
of any future large-scale randomized controlled trial to successfully recruit and be able to 
report on necessary outcomes. Here we will provide results across a range of outcomes which 
will provide estimates of efficacy to inform the design of a future full-scale randomized 
controlled trial of the ‘Living well with asthma’ website. 
Trial registration 
This trial is registered with Current Controlled Trials ISRCTN78556552 on 18/06/13. 
http://www.controlled-trials.com/ISRCTN78556552/raisin. 
Keywords 
Asthma, Self-management, Adherence, E-health, Randomized controlled trial, Complex 
intervention, Inhaled corticosteroids, Behaviour change 
Background 
Asthma is common, affecting an estimated 300 million people worldwide [1]. The financial 
costs associated with asthma care continue to increase [2], while care remains suboptimal - 
patients continue to overestimate their asthma control, tolerating more symptoms and greater 
limitations than necessary [3,4]. Promoting self-management, including the use of asthma 
action plans, along with regular health professional review has been shown to be an effective 
strategy leading to improved outcomes including improved quality of life, lower rates of 
healthcare contacts, and fewer days off work and school, and is a recommendation in 
worldwide asthma guidelines [5-9]. Self-management support aims to improve outcomes in a 
number of ways: better recognition of deterioration of symptoms, more appropriate responses 
to exacerbations, and optimizing adherence to medication [10]. Improving adherence to 
inhaled corticosteroids is crucial to avoid exacerbations, improve day to day control, and 
reduce the risk of hospitalization and death [11]. Adherence to treatments in many chronic 
illnesses is low and asthma is no exception [12,13]. Research into non-adherence suggests 
several rationales, but in common with other chronic conditions recurring themes relate to 
doubts about the need for the medications in the first place, and concerns about potential side-
effects of treatments [12,14]. 
Despite evidence of benefits, guided self-management remains underused [9-11]. Online 
interactive tools to support asthma self-management in general have been trialed out with the 
UK and there is increasing evidence that they may be safe and effective, enabling patients to 
take a more proactive role, improving asthma quality of life scores and symptoms (and in 
some cases forced expiratory volume in 1 second (FEV1) [15-18], and potentially 
demonstrating cost-effectiveness [19]. This suggests that making effective use of available 
technologies may have the potential to increase uptake of self-management behaviors in those 
with asthma, without additional cost. How best to achieve this is still not clear [20]. 
‘Living well with asthma’ resource development 
We developed an online resource ‘Living well with asthma’ which aims to promote optimal 
self-management behaviors known to lead to improved outcomes. Exploratory focus group 
discussions with adults with asthma and primary care nurses clarified the key features 
deemed most important in a website. These data, along with a preceding literature review 
[20], informed the initial development of a prototype of the website. The actual content of the 
pages within the website was developed and refined iteratively with input from adults with 
asthma, practice nurses, general practitioners, a sociologist, human computer interactions 
researchers, respiratory physicians, and a health psychologist. Further refinement of the 
content was undertaken using ‘Think aloud’ studies with adults with asthma. These were 
undertaken by DM, and participants fed back in real time their views on the contents and 
usability. Initially this was on paper mock-ups of proposed web pages, and latterly on actual 
‘Living well with asthma’ webpages. ‘Think aloud’ studies are a recognized method of 
gaining information about users’ views in real time as they navigate around a website, 
providing information about usability and feeding into further development and refinement of 
the website [21,22]. The ‘Living well with asthma’ website was developed as a standalone 
resource which should complement face-to-face asthma reviews, but does not require health 
professional involvement. 
A full description of the website development will be available in a forthcoming publication. 
Rationale for the evaluation methods 
Guidance for the development of complex interventions recommends pilot and feasibility 
studies prior to formal evaluations [23,24]. A pilot study is a version of the main study that is 
run in miniature to test whether the components of the main study can all work together [25], 
whereas a feasibility study is used to estimate important parameters that are needed to design 
the main study, such as ease of recruitment, standard deviations of outcome measures, and 
follow-up rates [25,26]. This study aims to address both issues. Feasibility and piloting are 
essential to ensure that planned progression to a full-scale randomized controlled trial (RCT) 
is appropriate in the first place and if it can be undertaken with appropriate power to achieve 
definitive results. This early evaluation must be broad enough to provide information both 
about how a full-scale RCT may work in practice but should also have consideration for how 
the resource may be used beyond the evaluation. Feasibility is investigated through 
measuring recruitment and retention rates and collecting usability data about the website 
itself. Measuring clinical outcomes will allow for the collection of important data on the 
efficacy of the intervention and for the estimation of effect sizes in any future larger RCT. 
Study aims 
This study aims firstly to assess the feasibility of conducting a RCT of the clinical 
effectiveness of an online asthma resource aimed at promoting adherence in adults with 
poorly controlled asthma, using the ‘Living well with asthma’ resource. Secondly, as a pilot 
study the aim is to provide estimates of recruitment and retention rates, as well as estimates 
of the variability of clinical and behavioral outcome measures to inform power calculations 
for a definitive trial. The study will collect a range of information about the way the 
intervention was used, including but not limited to: the most and least visited pages, the 
length of time the intervention was accessed, and how often it was accessed. Finally, this 
pilot and feasibility study also aims to identify any potential problems to be addressed, and 
allow for further development of the resource before a further evaluation. 
We hypothesize that this intervention, which has been designed with end user involvement 
and aims to improve adherence to therapy using multiple strategies (educational information, 
attitudinal arguments, self-monitoring, and reminders), will result in improved symptom 
control and quality of life measures in adults with asthma. 
Methods/Design 
Ethical approval and trial registration 
Ethical approval for this study was granted by the West of Scotland Research Ethics 
Committee (ref 13/WOS/004) in March 2013. All participants provided written informed 
consent. The trial was conducted in accordance with national laws, Good Clinical Practice 
guidelines and the Declaration of Helsinki 2002. This trial is registered with Current 
Controlled Trials ISRCTN78556552. 
Recruitment, randomization and blinding 
Participants are primarily being recruited from primary care practices within the Greater 
Glasgow and Clyde health board area and from posters in public places. We aim to recruit 50 
participants in total. See Table 1 for full eligibility criteria. 
Table 1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
1. Written informed consent 1. Unstable asthma 
2. Age 16 years or older 2. Presence of active lung disease other 
than asthma 
3. Diagnosis of asthma by a health professional and 
duration of asthma symptoms ≥ 1 year. 
3. Mental impairment or language 
difficulties that make informed consent 
impossible. 
4. Asthma Control Questionnaire score (6 questions 
version) greater than or equal to 1 (suggesting poorly 
controlled asthma) 
4. Terminal illness 
5. Ability to access the internet (excluding via smart 
phone or tablet). 
5. Cognitive impairment. 
Consenting participants fulfilling our inclusion and exclusion criteria are being randomized 
using a third party automated telephone interactive voice response system. Participants will 
self-complete all questionnaires. Due to the nature of the intervention the blinding of the 
researcher is not practical, however data will be entered and managed by the Robertson 
Centre for Biostatistics (RCB), University of Glasgow, and the researcher will take no role in 
this. The data will be analyzed by a researcher blinded to the allocation of the groups. 
Intervention 
This is a parallel two arm RCT. See study flow chart for details (Additional file 1, Figure 1). 
The duration of participation is 12 weeks from randomization. Those randomized to the 
intervention arm will have access to a purpose-built website with the aim of facilitating 
adherence to asthma medications for 12 weeks. This will include the following five areas: a) 
allow users to gain understanding of their current degree of asthma control and how they can 
improve it, specifically by optimizing their use of prescribed medication; b) challenge 
attitudes and concerns around taking medications for asthma; c) learn how to get the most out 
of their annual asthma review; d) prompt those who do not have one to seek an asthma action 
plan to be filled in with a health professional; e) send reminders to participants such as to get 
the flu vaccine or to order inhalers (participants can opt out of this aspect). 
Figure 1 Study flow chart. 
This resource will not advise medication changes directly, but if indicated, may suggest 
making an appointment with a nurse or doctor for review. Clear advice will be presented for 
seeking help in an emergency. 
ACQ, Asthma Control Questionnaire; AQLQ, Asthma Quality of Life Questionnaire; FeNO, 
Fractional Exhaled Nitric Oxide; GP, General Practitioner; MMAS, Morisky Medication 
Adherence Scale; PAM, Patient Activation Measure; PETS, Problems of Experienced 
Therapy Scale. 
Control group 
Those randomized to usual care will be advised to continue to manage their asthma as they 
would usually. After the follow-up visit at 12 weeks, participants in the control group will be 
offered 12 weeks of access to the website if they choose. 
Outcomes 
Primary endpoints 
The primary endpoints for this study are: recruitment and retention rates at 12 weeks from 
baseline, web usability, and changes at 12 weeks from baseline for ACQ [27] and AQLQ [28] 
scores. Recruitment and retention rates will be measured as well as usage data at 12 weeks, 
including number of times users logged in and total length of time logged in, number of times 
individual pages were viewed, and length of time spent on each page. 
Secondary endpoints 
The first secondary endpoint for this study will be changes at 12 weeks from baseline for 
Patient Activation Measure (PAM) score [29], EQ-5D score (generic measure of health 
related quality of life) [30], the Morisky Medication Adherence Scale (MMAS) [31], lung 
function (via pre bronchodilator spirometry FEV1, FEV1/FVC (forced vital capacity), peak 
expiratory flow (PEF) performed to American Thoracic Society (ATS) standards [32], and 
fractional exhaled nitric oxide levels (FeNO) performed to ATS standards [33]. 
The second secondary endpoint will be changes in the Problematic Experiences of Therapy 
Scale (PETS) [34] score at 12 weeks in the intervention group only. The third secondary 
endpoint will be self-reported healthcare utilization including: routine visit to GP or practice 
nurse because of asthma, visit to GP because of asthma requiring oral steroids, hospital 
admission (and length of stay) because of asthma requiring oral steroids, emergency or out of 
hours’ visit because of asthma requiring oral steroids, and emergency or out of hours’ visit of 
patients to the GP or GP visit to patient at home because of asthma requiring oral steroids. 
The fourth secondary endpoint will be self-reported medication utilization including: changes 
in the level of adherence to prescribed preventer medications, changes to the average number 
of reliever puffs taken per week, intensification of treatment, or step-up of asthma 
medications (as defined by British Thoracic Society/Scottish Intercollegiate Guidelines 
Network (BTS/SIGN) guidelines, and step-down of asthma medications (as defined by 
BTS/SIGN guidelines). 
Statistical considerations and data handling 
While this study is not powered to detect differences in clinical measures, we will report 
estimates of effect sizes with a 95% confidence interval. The primary objectives include 
determining recruitment and retention rates to inform the feasibility of running a full-scale 
trial. We shall recruit 50 participants to estimate these quantities with reasonable precision. 
For example, if we invite 100 participants to recruit 50, the recruitment rate would be 
estimated with a confidence interval of ± 10%. Patient characteristics and outcomes will be 
summarized at baseline, at follow-up, and as changes over baseline. Study groups will be 
compared using baseline-adjusted linear regression (analysis of covariance (ANCOVA). The 
effects of baseline and intermediate data on patient outcomes will be explored using linear 
regression. The variability of outcome data will be used to estimate the sample size required 
for a definitive study. 
Data management 
The RCB, part of the Glasgow Clinical Trials Unit (a fully registered UKCRN Clinical Trials 
Unit) are managing the randomization procedures and the trial data. Case report forms (CRF) 
will be used to collect study data. The CRF has been developed by the researcher and the 
RCB. The RCB are responsible for collating study data. 
Trial management group and patient safety 
The routine management of the trial will be coordinated by the trial management group. This 
will comprise the chief investigator (DM) and four co-investigators (FM, SW, NT, and AM). 
This group will monitor the progress of the trial to ensure that the protocol is adhered to. This 
group will meet bimonthly, with monthly recruitment reports via email. Any changes to the 
study protocol will be following agreement with the trial management group, and subject to 
approval from Research and Development at NHS Greater Glasgow and Clyde, and the West 
of Scotland Research Ethics Committee, where required. 
The study will end when the trial management group agrees that either the planned sample 
size has been achieved or the recruitment is so poor that completion of the trial is not feasible. 
Only adverse events that are outcome measures will be recorded. All serious adverse events 
(SAEs) will be recorded at follow-up. All SAEs will be assessed for causality, expectedness, 
and severity. This assessment is the responsibility of the chief investigator (CI). The trial 
team will record all SAEs. The CI will endeavor to obtain sufficient information to determine 
the causality of the adverse event and must provide an opinion of the causal relationship 
between each SAE and the study intervention. The accumulated SAEs will be sent to the 
sponsor and the West of Scotland Research Ethics Committee in an annual safety report. 
Detailed records of all SAEs will be held in the trial master file. 
Annual safety reports 
It shall be the responsibility of the trial management group on behalf of the sponsor to 
submit, once a year throughout the clinical trial, or on request, a safety report to the West of 
Scotland Research Ethics Committee. 
Discussion 
The increasing burden of chronic disease on healthcare providers is well known, and 
promoting self-care is a strategy for shifting this burden away from healthcare providers. The 
Internet may provide a cost-effective medium for doing this. Piloting of complex 
interventions is considered best practice and will maximize the potential of any future full-
scale RCT to successfully recruit and be able to report on necessary outcomes. Here we 
report on feasibility outcomes such as recruitment, retention, and usability of the intervention 
being investigated, and undertake piloting of an intervention which will aim to determine 
clinical efficacy. 
Trial status 
Recruitment was initiated in June 2013, with the first patient randomized in September 2013, 
and is ongoing as of February 2014. 
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